Abstract
Introduction
Inborn errors of tetrahydrobiopterin (BH4) biosynthesis or recycling are a group of very rare neurometabolic diseases. Following growing awareness and improved availability of drug treatment the number of patients with BH4 disorders reaching adulthood is constantly increasing. Pregnancy care of patients with these disorders is therefore a new challenge for clinicians.
Methods
This retrospective study summarises for the first time clinical and biochemical monitoring data of 16 pregnancies in seven women with different disorders of BH4 metabolism and evaluates treatment regimens before and during pregnancy in relation to the obstetrical outcome and paediatric follow-up.
Results
Worsening of pre-existing neurological symptoms or occurrence of new symptoms during pregnancy was not observed in most of the cases. Treatment regimens remained mostly unchanged. Pregnancies were not complicated by disease-specific features. Organ abnormalities, miscarriage, prematurity, IUGR and chromosomal changes were occasionally reported, without showing any association with the standard drug treatment for BH4 deficiencies.
Conclusion
Although our data on 16 pregnancies in seven patients did not present any association of standard drug treatment with an increased rate of pregnancy complications, abnormal obstetrical or paediatric outcome, an intensive clinical and biochemical supervision by a multidisciplinary team before, during and after the pregnancy in any BH4 deficiency is essential since available data on pregnancies in patients with BH4 deficiencies is limited.
Similar content being viewed by others
Abbreviations
- 5-HIAA:
-
5-Hydroxyindolacetic acid
- 5-HTP:
-
5-Hydroxytryptophan
- MHPG:
-
3-Methoxy-4-hydroxyphenylglycol
- 5-MTHF:
-
5-Methyltetrahydrofolic acid
- 3-OMD:
-
3-Orthomethyldopa
- PTPS:
-
6-Pyruvoyl-tetrahydrobiopterin synthase
- PTPS-D:
-
6-Pyruvoyl-tetrahydrobiopterin synthase deficiency
- ASD:
-
Atrial septal defect
- adGTPCH:
-
Autosomal dominant guanosine triphosphate cyclohydrolase 1
- adGTPCH-D:
-
Autosomal dominant guanosine triphosphate cyclohydrolase 1 deficiency
- arGTPCH:
-
Autosomal recessive guanosine triphosphate cyclohydrolase 1
- arGTPCH-D:
-
Autosomal recessive guanosine triphosphate cyclohydrolase 1 deficiency
- CSF:
-
Cerebral spinal fluid
- CNS:
-
Central nervous system
- DHPR:
-
Dihydropteridine reductase
- DHPR-D:
-
Dihydropteridine reductase deficiency
- DBS:
-
Dried blood spot
- GA:
-
Gestational age
- GW:
-
Gestational week
- HVA:
-
Homovanillic acid
- HPA:
-
Hyperphenylalaninemia
- iNTD:
-
International Working Group on Neurotransmitter Related Disorders
- IUGR:
-
Intrauterine growth restriction
- L-dopa:
-
Levodopa
- LSCS:
-
Lower segment caesarean section
- MPKU:
-
Maternal phenylketonuria
- MPKUS:
-
Maternal PKU syndrome
- NBS:
-
Newborn screening
- NOS:
-
Nitric oxide synthase
- PD:
-
Parkinson’s disease
- Phe:
-
Phenylalanine
- PAH:
-
Phenylalanine-4-hydroxylase
- PKU:
-
Phenylketonuria
- PCD:
-
Pterin-4 alpha-carbinolamine dehydratase
- SR:
-
Sepiapterin reductase
- SR-D:
-
Sepiapterin reductase deficiency
- BH4 :
-
Tetrahydrobiopterin
- TH:
-
Tyrosine hydroxylase
- TPH:
-
Tryptophan hydroxylase
References
Allain H, Bentue-Ferrer D, Milon D, Moran P, Jacquemard F, Defawe G (1989) Pregnancy and parkinsonism. A case report without problem. Clin Neuropharmacol 12(3):217–219
American Academy of Pediatrics Committee on Genetics (2008) Policy statement: maternal phenylketonuria. Pediatrics 122:445–449
Arai H, Shinotoh H, Hattori T (1997) L-dopa/benserazide during pregnancy in a patient with juvenile parkinsonism. Rinsho Shinkeigaku 37(3):264–265
Ball MC, Sagar HJ (1995) Levodopa in pregnancy. Mov Disord 10(1):115
Bartholome K (1974) Letter: a new molecular defect in phenylketonuria. Lancet 2(7896):1580
Basson CT, Cowley GS, Solomon SD et al (1994) The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med 330(13):885–891
Beck S, Wojdyla D, Say L et al (2010) The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 88(1):31–38
Benbir G, Ertan S, Ozekmekci S (2014) Successful pregnancy and delivery in a patient with Parkinson's disease under pramipexole treatment. Presse Med 43(1):83–85
Benetello P, Furlanut M, Zara G, Baraldo M, Hassan E (1993) Plasma levels of levodopa and its main metabolites in parkinsonian patients after conventional and controlled-release levodopa-carbidopa associations. Eur Neurol 33(1):69–73
Benito-Leon J, Bermejo F, Porta-Etessam J (1999) Pregnancy in Parkinson's disease: a review of the literature and a case report. Mov Disord 14(1):194
Blau N, Thöny B, Cotton R, Hyland K (2001) Disorders of tetrahydrobiopterin and related biogenic amines. McGraw-Hill, New York
Blau N, van Spronsen FJ (2014) Disorders of phenylalanine and tetrahydrobiopterin metabolism. In: Blau N, Duran M, Dionisi-vici C (eds) Physician's guide to the diagnosis, treatment, and follow-up of inherited metabolic diseases. Springer, Heidelberg, pp 3–21
Bruggemann N, Spiegler J, Hellenbroich Y et al (2012) Beneficial prenatal levodopa therapy in autosomal recessive guanosine triphosphate cyclohydrolase 1 deficiency. Arch Neurol 69(8):1071–1075
Brunelli S, Faiella A, Capra V et al (1996) Germline mutations in the homeobox gene EMX2 in patients with severe schizencephaly. Nat Genet 12(1):94–96
Capra V, De Marco P, Moroni A et al (1996) Schizencephaly: surgical features and new molecular genetic results. Eur J Pediatr Surg 6(Suppl 1):27–29
Choi TY, Lee HM, Park WK, Jeong SY, Moon HS (2014) Spontaneous abortion and recurrent miscarriage: a comparison of cytogenetic diagnosis in 250 cases. Obstet Gynecol Sci 57(6):518–525
Cook DG, Klawans HL (1985) Levodopa during pregnancy. Clin Neuropharmacol 8(1):93–95
Dhondt J-L (2006) Follow-up and outcome of tetrahydrobiopterin deficiencies. In Blau, N PKU and BH4: advances in phenylketonuria and tetrahydrobiopterin. Heilbronn, SPS Verlagsgesellschaft, pp 652–677
Dostal M, Weber-Schoendorfer C, Sobesky J, Schaefer C (2013) Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series. Eur J Neurol 20(9):1241–1246
Douglas G, Hale AB, Crabtree MJ et al (2015) A requirement for Gch1 and tetrahydrobiopterin in embryonic development. Dev Biol 399(1):129–138
Feillet F, Muntau AC, Debray FG et al (2014) Use of sapropterin dihydrochloride in maternal phenylketonuria. A European experience of eight cases. J Inherit Metab Dis 37(5):753–762
Felix JF, de Jong EM, Torfs CP, de Klein A, Rottier RJ, Tibboel D (2009) Genetic and environmental factors in the etiology of esophageal atresia and/or tracheoesophageal fistula: an overview of the current concepts. Birth Defects Research Part A: Clin Molec Teratol 85(9):747–754
Fenton TR, Kim JH (2013) A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 13:59
Friedman J, Roze E, Abdenur JE et al (2012) Sepiapterin reductase deficiency: a treatable mimic of cerebral palsy. Ann Neurol 71(4):520–530
Gershanik OS, Leist A (1987) Juvenile onset Parkinson's disease. Adv Neurol 45:213–216
Gizewska M, Hnatyszyn G, Sagan L et al (2009) Maternal tetrahydrobiopterin deficiency: the course of two pregnancies and follow-up of two children in a mother with 6-pyruvoyl-tetrahydropterin synthase deficiency. J Inherit Metab Dis 32(Suppl 1):S83–S89
Golbe LI (1987) Parkinson's disease and pregnancy. Neurology 37(7):1245–1249
Grange DK, Hillman RE, Burton BK et al (2014) Sapropterin dihydrochloride use in pregnant women with phenylketonuria: an interim report of the PKU MOMS sub-registry. Mol Genet Metab 112(1):9–16
Hagell P, Odin P, Vinge E (1998) Pregnancy in Parkinson's disease: a review of the literature and a case report. Mov Disord 13(1):34–38
Hanley WB, Clarke JT, Schoonheyt W (1987) Maternal phenylketonuria (PKU)--a review. Clin Biochem 20(3):149–156
Howe DT, Rankin J, Draper ES (2012) Schizencephaly prevalence, prenatal diagnosis and clues to etiology: a register-based study. Ultrasound Obstet Gynecol 39(1):75–82
Irons M, Levy HL, O'Flynn ME et al (1987) Folinic acid therapy in treatment of dihydropteridine reductase deficiency. J Pediatr 110(1):61–67
Jacquemard F, Palaric JC, Allain H, Giraud JR (1990) Parkinson disease and pregnancy. Apropos of a case. J Gynecol Obstet Biol Reprod (Paris) 19(4):461–463
Jaggi L, Zurfluh MR, Schuler A et al (2008) Outcome and long-term follow-up of 36 patients with tetrahydrobiopterin deficiency. Mol Genet Metab 93(3):295–305
Koch R, Moseley K, Guttler F (2005) Tetrahydrobiopterin and maternal PKU. Mol Genet Metab 86(Suppl 1):S139–S141
Kranick SM, Mowry EM, Colcher A, Horn S, Golbe LI (2010) Movement disorders and pregnancy: a review of the literature. Mov Disord 25(6):665–671
Levy HL (2003) Historical background for the maternal PKU syndrome. Pediatrics 112(6 Pt 2):1516–1518
Mabry CC, Denniston JC, Nelson TL, Son CD (1963) Maternal phenylketonuria. A cause of mental retardation in children without the metabolic defect. N Engl J Med 269:1404–1408
McIntyre S, Badawi N, Blair E, Nelson KB (2015) Does aetiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy influence the outcome of treatment? Dev Med Child Neurol 57(Suppl 3):2–7
Merchant CA, Cohen G, Mytilineou C et al (1995) Human transplacental transfer of carbidopa/levodopa. J Neural Transm Park Dis Dement Sect 9(2–3):239–242
Mucchiut M, Belgrado E, Cutuli D, Antonini A, Bergonzi P (2004) Pramipexole-treated Parkinson's disease during pregnancy. Mov Disord 19(9):1114–1115
Murphy E (2015) Pregnancy in women with inherited metabolic disease. Obstet Med 8(2):61–67
Narisawa K, Arai N, Ishizawa S et al (1980) Dihydropteridine reductase deficiency: diagnosis by leukocyte enzyme assay. Clin Chim Acta 105(3):335–342
Nassar N, Leoncini E, Amar E et al (2012) Prevalence of esophageal atresia among 18 international birth defects surveillance programs. Birth Defects Res Part A: Clin Molec Teratol 94(11):893–899
Neilson JP, Gyte GM, Hickey M, Vazquez JC, Dou L (2013) Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev 3:CD007223
Nomoto M, Kaseda S, Iwata S, Osame M, Fukuda T (1997) Levodopa in pregnancy. Mov Disord 12(2):261
Opladen T, Cortès-Saladelafont E, Mastrangelo M et al (2016) The InternationalWorking group on neurotransmitter related disorders (iNTD): a worldwide research project focused on primary and secondary neurotransmitter disorders. Molec Genet Metab Rep 9:61–66
Opladen T, Hoffmann G, Horster F et al (2011) Clinical and biochemical characterization of patients with early infantile onset of autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia. Mov Disord 26(1):157–161
Opladen T, Hoffmann GF, Blau N (2012) An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia. J Inherit Metab Dis 35(6):963–973
Pini Prato A, Carlucci M, Bagolan P et al (2015) A cross-sectional nationwide survey on esophageal atresia and tracheoesophageal fistula. J Pediatr Surg 50(9):1441–1456
Ponzone A, Ferraris S, Baglieri S,Spada M (2006) Treatment of tetrahydrobiopterin deficiencies. In Blau, N PKU and BH4: advances in phenylketonuria and tetrahydrobiopterin. Heilbronn, SPS Verlagsgesellschaft, pp 612–637
Rey F, Blandin-Savoja F, Rey J (1976) Atypical phenylketonuria with normal dihydropteridine reductase activity. N Engl J Med 295(20):1138–1139
Routiot T, Lurel S, Denis E, Barbarino-Monnier P (2000) Parkinson's disease and pregnancy: case report and literature review. J Gynecol Obstet Biol Reprod (Paris) 29(5):454–457
Scott M, Chowdhury M (2005) Pregnancy in Parkinson's disease: unique case report and review of the literature. Mov Disord 20(8):1078–1079
Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H (1976) Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 14:215–233
Segawa M, Nomura Y, Nishiyama N (2003) Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 54(Suppl 6):S32–S45
Serikawa T, Shimohata T, Akashi M et al (2011) Successful twin pregnancy in a patient with parkin-associated autosomal recessive juvenile parkinsonism. BMC Neurol 11:72
Sharma D, Shastri S, Sharma P (2016) Intrauterine growth restriction: antenatal and postnatal aspects. Clin Med Insights Pediatr 10:67–83
Shintaku H, Ohwada M (2013) Long-term follow-up of tetrahydrobiopterin therapy in patients with tetrahydrobiopterin deficiency in Japan. Brain Develop 35(5):406–410
Shulman LM, Minagar A, Weiner WJ (2000) The effect of pregnancy in Parkinson's disease. Mov Disord 15(1):132–135
Steinberger D, Blau N, Goriuonov D et al (2004) Heterozygous mutation in 5′-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonia. Neurogenetics 5(3):187–190
Thony B, Blau N (2006) Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase. Hum Mutat 27(9):870–878
Trender-Gerhard I, Sweeney MG, Schwingenschuh P et al (2009) Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry 80(8):839–845
van der Linde D, Konings EE, Slager MA et al (2011) Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 58(21):2241–2247
van Spronsen FJ, van Wegberg AM, Ahring K et al (2017) Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol 5(9):743–756
Ventzke A, Hoffmann J, Crushell E, Monavari A, Mayne PD, Knerr I (2015) 'Malignant Phenylketonuria' (PKU) due to Dihydropteridine reductase (DHPR) deficiency. Ir Med J 108(10):312–314
Voigt M, Zels K, Guthmann F, Hesse V, Gorlich Y, Straube S (2011) Somatic classification of neonates based on birth weight, length, and head circumference: quantification of the effects of maternal BMI and smoking. J Perinat Med 39(3):291–297
Volpe JJ (2012) Neonatal encephalopathy: an inadequate term for hypoxic-ischemic encephalopathy. Ann Neurol 72(2):156–166
von Graevenitz KS, Shulman LM, Revell SP (1996) Levodopa in pregnancy. Mov Disord 11(1):115–116
Watanabe T, Matsubara S (2012) Good obstetric outcome in a patient with Segawa disease. Arq Neuropsiquiatr 70(7):559–560
Watanabe T, Matsubara S, Baba Y, Tanaka H, Suzuki T, Suzuki M (2009) Successful management of pregnancy in a patient with Segawa disease: case report and literature review. J Obstet Gynaecol Res 35(3):562–564
Werner ER, Blau N, Thony B (2011) Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J 438(3):397–414
Acknowledgements
We thank Dr. D. Hübschmann and Dr N. Ishaque for fruitful discussion. This study was partially supported by Dietmar Hopp Stiftung, St. Leon-Rot, Germany.
Funding
No funding was provided for this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
O. Kuseyri, A. Weissbach, N. Bruggemann, C. Klein, M. Giżewska, D. Karall, S. Scholl-Bürgi, H. Romanowska, E. Krzywińska-Zdeb, A.A. Monavari, I. Knerr, Z. Yapıcı, V. Leuzzi, and T. Opladen declare that they have no conflict of interest.
Studies with animal
This article does not contain any studies with animal subjects performed by the any of the authors.
Additional information
Communicated by: Francois Feillet
Electronic supplementary material
ESM 1
(DOCX 31 kb)
Rights and permissions
About this article
Cite this article
Kuseyri, O., Weissbach, A., Bruggemann, N. et al. Pregnancy management and outcome in patients with four different tetrahydrobiopterin disorders. J Inherit Metab Dis 41, 849–863 (2018). https://doi.org/10.1007/s10545-018-0169-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-018-0169-0